EVALUATION OF BIOMARKERS OF TRAUMATIC BRAIN INJURY EXTENSION STUDY



Status:Completed
Conditions:Hospital, Neurology
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:18 - Any
Updated:8/9/2017
Start Date:June 2015
End Date:November 2016

Use our guide to learn which trials are right for you!

A PROSPECTIVE CLINICAL EVALUATION OF BIOMARKERS OF TRAUMATIC BRAIN INJURY EXTENSION STUDY

The primary objective of this study is to evaluate Ubiquitin C-terminal Hydrolase-L1 (UCH-L1)
and Glial Fibrillary Acidic Protein (GFAP) biomarker levels in a population of CT-positive
subjects (as determined by an independent Neuroimaging Review Committee) presenting acutely
with traumatic brain injury (Glasgow Coma Scale score 9-15).


Inclusion Criteria:

- The Subject is at least 18 years of age at screening.

- The Subject has presented to a Health Care Facility (HCF) or Emergency Department (ED)
with a suspected traumatically induced head injury, as a result of insult to the head
from an external force.

- A Glasgow Coma Scale score of 9-15 at the time of Informed Consent.

- The subject is CT-positive for acute intracranial lesion(s) based on the local
neuroradiologist's review of the subject's head CT scan.

- The CT scan and CT report used to determine eligibility must be available.

- The blood sample is collected as close to the time of head injury as possible, but no
later than 12 hours.

- The Subject or their legal representative is willing to undergo the Informed Consent
process prior to enrollment into this study

Exclusion Criteria:

- Participating in an interventional, therapeutic clinical study that may affect the
results of this study (an observational study would be acceptable).

- Time of injury cannot be determined.

- Primary diagnosis of ischemic or hemorrhagic stroke.

- Venipuncture not feasible (i.e., skin integrity compromised at the venipuncture sites,
blood vessel calcification (i.e., IV drug users, advanced atherosclerosis) both upper
limbs missing (congenital or amputee)).

- The subject has a neurodegenerative disease or other neurological disorder including
dementia, Parkinson's disease, multiple sclerosis, seizure disorder, or brain tumors.

- The subject has a history of neurosurgery within the last 30 days.

- Administration of blood transfusion after head injury and prior to the study blood
draw.

- The subject is a female who is pregnant or lactating.

- The Subject is otherwise determined by the Investigator to be an unsuitable candidate
for participation. If this criterion applies, a reason must be provided
We found this trial at
6
sites
Richmond, Virginia 23298
(804) 828-0100
Principal Investigator: V. Ramana Feeser, MD
Virginia Commonwealth University Since our founding as a medical school in 1838, Virginia Commonwealth University...
?
mi
from
Richmond, VA
Click here to add this to my saved trials
Charlottesville, Virginia 22903
(434) 924-0311
Principal Investigator: Stephen Huff, MD
University of Virginia The University of Virginia is distinctive among institutions of higher education. Founded...
?
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Detroit, Michigan 48201
Principal Investigator: Robert Welch, MD
?
mi
from
Detroit, MI
Click here to add this to my saved trials
Houston, Texas 77030
Principal Investigator: Frank Peacock, MD
?
mi
from
Houston, TX
Click here to add this to my saved trials
Munich, 80336
Principal Investigator: Viktoria Bogner, MD
?
mi
from
Munich,
Click here to add this to my saved trials
San Diego, California 92093
Principal Investigator: Raul Coimbra, MD
?
mi
from
San Diego, CA
Click here to add this to my saved trials